Retrospective molecular analysis of this tumor revealed a pathologic POLE-EDM (p.V411L) as well as a loss in MMR protein PMS2 and according to the FIGO 2023 classification would now be categorized as stage IAmPOLEmut. Here, POLE is linked to neoplasm.